Shinji Yamada

4.2k total citations
167 papers, 2.8k citations indexed

About

Shinji Yamada is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Shinji Yamada has authored 167 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 41 papers in Surgery and 40 papers in Molecular Biology. Recurrent topics in Shinji Yamada's work include Lymphatic System and Diseases (42 papers), Lymphatic Disorders and Treatments (34 papers) and Vector-borne infectious diseases (23 papers). Shinji Yamada is often cited by papers focused on Lymphatic System and Diseases (42 papers), Lymphatic Disorders and Treatments (34 papers) and Vector-borne infectious diseases (23 papers). Shinji Yamada collaborates with scholars based in Japan, Thailand and Brazil. Shinji Yamada's co-authors include Yukinari Kato, Mika K. Kaneko, Shunsuke Itai, Takuro Nakamura, Satoru Konnai, Miyuki Yanaka, Hiroyuki Harada, Yoshikazu Furusawa, Kazuhiko Ohashi and Masato Sano and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Shinji Yamada

162 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shinji Yamada Japan	31	1.2k	805	763	515	445	167	2.8k
Magdalena Tary‐Lehmann United States	37	487 0.4×	2.9k 3.6×	628 0.8×	618 1.2×	603 1.4×	81	4.6k
Martha B. Furie United States	30	324 0.3×	959 1.2×	1.1k 1.5×	153 0.3×	605 1.4×	51	3.2k
Gayle C. Bosma United States	21	768 0.7×	2.3k 2.9×	1.3k 1.7×	189 0.4×	250 0.6×	42	4.2k
Nancy Noben-Trauth United States	28	766 0.7×	3.7k 4.6×	650 0.9×	216 0.4×	347 0.8×	38	5.9k
Brian J. Thomson United Kingdom	31	748 0.6×	399 0.5×	377 0.5×	162 0.3×	480 1.1×	79	3.1k
Marvin S. Reitz United States	36	1.5k 1.3×	1.8k 2.2×	1.3k 1.7×	248 0.5×	828 1.9×	90	5.0k
Leopoldo Flores‐Romo Mexico	29	628 0.5×	3.0k 3.7×	662 0.9×	173 0.3×	472 1.1×	96	4.3k
Óscar R. Burrone Italy	41	565 0.5×	1.1k 1.4×	1.4k 1.9×	167 0.3×	1.6k 3.6×	150	4.9k
Benjamin E. Gewurz United States	37	1.5k 1.3×	1.5k 1.9×	1.2k 1.5×	88 0.2×	484 1.1×	81	3.9k
Melvin J. Bosma United States	33	1.3k 1.1×	4.1k 5.1×	2.3k 3.1×	324 0.6×	350 0.8×	81	7.0k

Countries citing papers authored by Shinji Yamada

Since Specialization

Citations

This map shows the geographic impact of Shinji Yamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinji Yamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinji Yamada more than expected).

Fields of papers citing papers by Shinji Yamada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinji Yamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinji Yamada. The network helps show where Shinji Yamada may publish in the future.

Co-authorship network of co-authors of Shinji Yamada

This figure shows the co-authorship network connecting the top 25 collaborators of Shinji Yamada. A scholar is included among the top collaborators of Shinji Yamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinji Yamada. Shinji Yamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Satō, Masaki, Mitsuyo Matsumoto, Yuriko Saiki, et al.. (2020). BACH1 Promotes Pancreatic Cancer Metastasis by Repressing Epithelial Genes and Enhancing Epithelial–Mesenchymal Transition. Cancer Research. 80(6). 1279–1292. 82 indexed citations

Takei, Junko, Yoshikazu Furusawa, Shinji Yamada, et al.. (2019). PMab-247 Detects Bear Podoplanin in Immunohistochemical Analysis. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(4). 171–174. 13 indexed citations

Takei, Junko, Shinji Yamada, Satoru Konnai, et al.. (2019). PMab-241 Specifically Detects Bear Podoplanin of Lymphatic Endothelial Cells in the Lung of Brown Bear. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(6). 282–284. 8 indexed citations

Kato, Yukinari, Tomokazu Ohishi, Shinji Yamada, et al.. (2019). Anti-CD133 Monoclonal Antibody CMab-43 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(2). 75–78. 13 indexed citations

Kato, Yukinari, Tomokazu Ohishi, Shinji Yamada, et al.. (2019). Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H ₂ Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon Cancer. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(4). 157–161. 12 indexed citations

Takei, Junko, Shunsuke Itai, Hiroyuki Harada, et al.. (2019). Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat Tissues. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(5). 213–219. 8 indexed citations

Kato, Yukinari, Junko Takei, Yoshikazu Furusawa, et al.. (2019). Epitope Mapping of Anti-Bear Podoplanin Monoclonal Antibody PMab-247. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(5). 230–233. 12 indexed citations

Furusawa, Yoshikazu, Mika K. Kaneko, Takuro Nakamura, et al.. (2019). Establishment of a Monoclonal Antibody PMab-231 for Tiger Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(2). 89–95. 42 indexed citations

Kato, Daiki, Masaya Tsuboi, Ryohei Yoshitake, et al.. (2019). Evaluation of immunohistochemical staining with PMab-38, an anti-dog podoplanin monoclonal antibody, in various canine tumor tissues. Jūigaku kenkyū/Japanese journal of veterinary research. 67(1). 25–34. 3 indexed citations

10.

Yamada, Shinji, Shunsuke Itai, Takuro Nakamura, et al.. (2018). Monoclonal Antibody L ₁ Mab-13 Detected Human PD-L1 in Lung Cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(2). 110–115. 45 indexed citations

11.

Yamada, Shinji, Shunsuke Itai, Mika K. Kaneko, & Yukinari Kato. (2018). Anti-Podocalyxin Monoclonal Antibody 47-mG _2a Detects Lung Cancers by Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(2). 91–94. 5 indexed citations

12.

Kato, Yukinari, Shinji Yamada, Shunsuke Itai, et al.. (2018). Detection of Alpaca Podoplanin by Immunohistochemistry Using the Antibovine Podoplanin Monoclonal Antibody PMab-44. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(6). 269–271. 4 indexed citations

13.

Kato, Yukinari, Takuya Mizuno, Shinji Yamada, et al.. (2018). Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(5). 218–223. 11 indexed citations

14.

Yamada, Shinji, Mika K. Kaneko, Yoshikazu Furusawa, et al.. (2018). Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38(2). 96–99. 4 indexed citations

15.

Kato, Yukinari, Shinji Yamada, Shunsuke Itai, et al.. (2018). Anti-Horse Podoplanin Monoclonal Antibody PMab-219 is Useful for Detecting Lymphatic Endothelial Cells by Immunohistochemical Analysis. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 37(6). 272–274. 17 indexed citations

16.

Nakano, Tomoyuki, Satoshi Ogasawara, Toshiaki Tanaka, et al.. (2017). DaMab-2: Anti-Human DGKα Monoclonal Antibody for Immunocytochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(4). 181–184. 8 indexed citations

17.

Itai, Shunsuke, Mika K. Kaneko, Yuki Fujii, et al.. (2017). Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(5). 214–219. 12 indexed citations

18.

Itai, Shunsuke, Shinji Yamada, Mika K. Kaneko, et al.. (2017). Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(6). 272–281. 16 indexed citations

19.

Itai, Shunsuke, Yuki Fujii, Takuro Nakamura, et al.. (2017). Establishment of CMab-43, a Sensitive and Specific Anti-CD133 Monoclonal Antibody, for Immunohistochemistry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 36(5). 231–235. 59 indexed citations

20.

Takahashi, Toru, Takehiko Abe, Takafumi Saito, et al.. (1990). PERITONEOSCOPIC FINDINGS OF ALCOHOLIC LIVER INJURY WITH SPECIAL REFERRENCE TO HISTOLOGICAL CHANGES. Acta gastro-enterologica belgica. 32(6). 1341–1353.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact